Henry Schein | HSIC - Ebitda

Stock Price
73.13
Daily Change
-2.18 -2.89%
Monthly
-6.89%
Yearly
-9.25%
Q1 Forecast
73.16

Henry Schein reported $295M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Agilent USD 466M 5M Jun/2025
Align Technology USD 203.61M 66M Jun/2025
Bruker USD 128.1M 27.1M Jun/2025
Cardinal Health USD 986M 319M Sep/2025
Charles River Laboratories USD 282.89M 64.81M Sep/2025
Cigna USD 2.86B 56M Mar/2025
Cooper Companies USD 336.6M 14.8M Sep/2025
CVS Health USD 4.09B 392M Sep/2025
Danaher USD 2.13B 252M Dec/2025
Dentsply International USD 167M 30M Sep/2025
Encompass Health USD 300.1M 18.5M Sep/2025
Henry Schein USD 295M 39M Sep/2025
Idexx Laboratories USD 391.47M 17.97M Sep/2025
IQVIA Holdings USD 949M 39M Sep/2025
Laboratory Of America USD 633.6M 135.6M Jun/2025
McKesson USD 1.68B 418M Sep/2025
Mettler Toledo International USD 322.64M 26.75M Sep/2025
Owens Minor USD 96.6M 12.17M Jun/2025
Quest Diagnostics USD 561M 9M Sep/2025
Revvity USD 248.91M 48.52M Dec/2025
Stryker USD 1.67B 206M Sep/2025
Tenet Healthcare USD 1.1B 22M Sep/2025
Thermo Fisher Scientific USD 3.17B 335M Dec/2025
Universal Health Services USD 670.6M 27.72M Sep/2025
Waters USD 295.14M 18.87M Sep/2025
Zimmer Biomet Holdings USD 575.7M 26.1M Jun/2025
Zoetis USD 1.04B 87M Sep/2025